Navigation Links
Study Reports Successful Cloning of Human Embryo Using Adult DNA
Date:1/17/2008

rts from a South Korean research group. Amidst this background of controversy, the researchers took extraordinary steps to ensure that their experiments were properly conducted and documented. These included approval by an independent review board and confirmation of the genetic results by an independent laboratory, among other steps.

The ability to generate stem cells using the patient's own DNA holds great promise for the treatment of currently incurable degenerative diseases, as well as for cell-based drug discovery. Previous studies reporting the development of cloned human embryos have used embryonic stem cells as the DNA donors.

"This study demonstrates, for the first time, that SCNT can be utilized to generate cloned human blastocysts using differentiated adult donor nuclei remodeled and reprogrammed by human oocytes," the researchers write. They believe that some key technical factors contributed to their successful results, including the use of freshly donated oocytes from successful egg donors.

While the study is an important step toward the development of stem cells for therapeutic cloning, much more research will be needed to confirm and extend the results. Dr. French comments, "The data we present are not in any way the final word on this topic, but, we anticipate, just one of many publications from a variety of researchers who will use a variety of methods to conduct and analyze similar experiments."

Dr. Miodrag Stojkovic, Co-Editor of "Stem Cells," comments: "These researchers have for the first time developed cloned embryos up to blastocyst stage using adult somatic [skin] cells as donor cells. This is a key advance in the development of patient-specific stem cell lines for therapeutic and drug development purposes. Although these results are preliminary since no stem cell lines have been derived from the cloned embryos, this may now be attempted."

The article, entitled "Development of Human Cloned Blastocysts Follo
'/>"/>

SOURCE AlphaMed Press
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
2. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
3. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
4. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
5. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
6. Schering-Plough Reports Top-Line Results of the IDEAL Study
7. Positive Results from Phase IIa Study Pave Way for Phase IIb Trial of DG051 for the Prevention of Heart Attack
8. Knee Pain? An Exclusive Study Engineers Cartilage to Match Patients Own Tissue
9. Vion Pharmaceuticals Announces FDA Lift of Clinical Hold on Phase III Study of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed AML
10. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
11. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... y LONDRES, August 29, 2015 ... para los sistemas de imagen por Ultrasonidos ... Ecografía, tiempos de examen rápidos y un flujo de ... confianza diagnóstica en el proceso de detección de Cardiopatías ... PHIA) ha anunciado hoy el lanzamiento europeo de ...
(Date:8/28/2015)... According to a new market ... Prostate) Type (Protein & Genetic Biomarkers) Profiling Technology (Proteomics, ... Geography - Global Forecast to 2020", published by MarketsandMarkets, ... 17,689.0 Million USD by 2020 at a CAGR of ... Browse 191 Tables and 38 F ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on China,s ... Tobramycin is a traditional antibiotic whose eye drop ... the treatment of potential infection or inflammation caused by ... China are able to produce tobramycin, among ...
Breaking Medicine Technology:Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5Investigation Report on China's Tobramycin Market, 2015-2019 2
... NEW YORK, Sept. 27 Keryx Biopharmaceuticals, Inc. (Nasdaq: ... Chief Executive Officer, will be presenting at the JMP Securities ... in New York City.  Mr. Bentsur,s presentation is scheduled to ... A live audio webcast of Mr. Bentsur,s presentation ...
... Mass., Sept. 25 Boston Scientific Corporation (NYSE: ... data from the HORIZONS-AMI trial.  The trial, sponsored ... support from Boston Scientific and The Medicines Company ... determine the safety and efficacy of the TAXUS® ...
Cached Medicine Technology:Keryx Biopharmaceuticals to Present at JMP Securities Healthcare Conference 2HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients 2HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients 3HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients 4
(Date:8/31/2015)... New York, New York (PRWEB) , ... August 31, 2015 , ... ... eyes to autumn, when play-offs and the World Series will dominate the sports world. ... its division and eventually advance to the final series. For children, especially those who ...
(Date:8/31/2015)... ... August 31, 2015 , ... Castle Dermatology Institute now ... Dr. Pedram Ghasri is a graduate of the University of California, Los Angeles. He ... studies at the University of California, Irvine Medical School. As a nationally recognized Regents ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... Month 2015 in September by sharing the facts about the role of heredity ... and BRCA2 genetic mutations because of Angelina Jolie Pitt’s decisions to have both ...
(Date:8/31/2015)... ... August 31, 2015 , ... In preparation for this November’s National ... the BEAN™ personal sound amplifier, is offering caregivers “7 Reasons to Care about Hearing ... of coping with a variety of home healthcare challenges, specifically as they relate to ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... airway management device that could effectively deliver oxygen with a lower risk of ... a better way, I invented the Adam Device." , The Adam Device offers ...
Breaking Medicine News(10 mins):Health News:New Children's Baseball Series Offers Young Fans a Way to Celebrate the World Series 2Health News:Castle Dermatology Institute Now Welcomes Dr. Pedram Ghasri to the Practice 2Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 2Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 3Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 4Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 3Health News:InventHelp® Client's Invents Medical Device to Restore Respiratory Function (BGF-905) 2
... ago, a large biotech company began collecting ePRO ... tablet system in clinical trials around the world. ... using the assisTek system compared to what it ... traditional paper questionnaires. The results showed that assisTek,s ...
... led the University of California, San Francisco for the past 10 years, ... 2009. , ... (Vocus) October, 24, 2008 -- Chancellor J. Michael Bishop, ... past 10 years, today announced plans to step down from his post, ...
... including free sessions -- is,now open at ... This November, the,international grassroots organization, Children ... 20th annual,international conference at the Anaheim Hilton, ... an exceptional opportunity to connect,with parents, teachers, ...
... With the,number of visitors to Internet drug outlets nearly ... is higher than ever. Based on its,assessment of more ... Association of Boards of Pharmacy(R) (NABP(R)) finds,that 97% of ... with state,and federal laws or established patient safety and ...
... Oct. 23 Halloween can be,filled with tricks and ... The California Poison Control System (CPCS) urges parents to ... while,decreasing risk., If parents have questions, the CPCS ... a week for immediate expert help and information in,case ...
... Oct. 23 LifeSync Corporation,announced it has entered ... comprised of 12,000 members in 20 states, for ... ECG LeadWear(R) products., Shelley Hartman, President of ... this agreement with MAGNET. MAGNET is a major ...
Cached Medicine News:Health News:assisTek's ePRO Biotech Clinical Trial Data Collection Saves Client $1.6 Million Over Paper Questionnaires 2Health News:UCSF Chancellor J. Michael Bishop Announces Plan To Step Down 2Health News:UCSF Chancellor J. Michael Bishop Announces Plan To Step Down 3Health News:UCSF Chancellor J. Michael Bishop Announces Plan To Step Down 4Health News:UCSF Chancellor J. Michael Bishop Announces Plan To Step Down 5Health News:UCSF Chancellor J. Michael Bishop Announces Plan To Step Down 6Health News:UCSF Chancellor J. Michael Bishop Announces Plan To Step Down 7Health News:CHADD to Host International Conference on AD/HD in Anaheim, CA; Olympian Bruce Jenner to Keynote 2Health News:NABP Findings Underscore Dangers of Purchasing Prescription Medicine Online and From Foreign Sources 2Health News:NABP Findings Underscore Dangers of Purchasing Prescription Medicine Online and From Foreign Sources 3Health News:Celebrate Halloween Safely This Year With Tips From the California Poison Control System 2
... new generation of posterior stabilized knee ... the following: Patellar flange mates with ... machined condyles assure precise, repeatable kinematics ... and patella to reduce wear. Constant ...
... total knee prosthesis stems from many years ... and manufacturing technologies have been used in ... well as a favorable pressure distribution pattern ... wear to a minimum. The inherent design ...
The Balanced Knee System provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results....
... Knee System provides anatomical replacement of all ... preserving the stabilizing Anterior and Posterior Ligaments, ... of the knee. All the components in ... and are equally proportioned and contoured to ...
Medicine Products: